Browse 23 Cochlear Implant Medical Studies Across 32 Cities
58 Cochlear Implant Clinics
Individuals with bilateral sensorineural hearing loss have benefited from cochlear implant (CI) technology, which transmits sound signals directly to the brain instead of the damaged inner ear. In the United States, the Food and Drug Administration (FDA) has just recently authorized the use of cochlear implants to treat single-sided deafness.
What Are Cochlear Implant Clinical Trials?
A major goal of many Cochlear Implant Clinical Trials is to better understand the effects of abnormal auditory input on the brainstem and the effects of the brain on activity in the ear via efferent feedback loops.
Research at the Johns Hopkins Cochlear Implant Center focuses on the interaction between environmental noise and various forms of hearing loss (including hereditary, conductive, noise-induced, age-related, and traumatic brain injury-related loss of hearing).
Why is Cochlear Implant Treatment Studied in Clinical Trials?
The relationship between central auditory processing deficiencies, tinnitus, and hyperacusis, and the plastic changes in the brain that compensate for some parts of altered auditory input, are of particular interest. Having a firm grasp on these shifts will allow for the development of more effective therapy tactics and the discovery of novel treatment targets.
How Does Cochlear Implant Treatment Work?
Hearing aids and cochlear implants are two very different types of medical technology. A cochlear implant offers the feeling of sound by stimulating the auditory nerve directly, rather than through amplification, which aids a person with residual hearing ability.
Those who are profoundly hard of hearing or deaf can experience the sense of sound with a cochlear implant by avoiding the damaged inner ear, but this does not mean that the implant will cure or restore their hearing.
Unlike hearing aids, they require surgical implantation.
Candidates for a cochlear implant
Cochlear implants can be given to children as young as 12 months who have been diagnosed with profound hearing loss. A child’s eligibility is determined by whether they meet the following criteria:
More and more adults are opting to have cochlear implants. Loss of hearing at any point in adulthood, including after language acquisition, does not disqualify a person from receiving a cochlear implant. Success rates with cochlear implants are higher among adults who acquired language before to deafness (prelingually deafened) than among those who did not acquire language prior to deafness (prelingually deafened).
In most cases, persons who match one of the following requirements are good candidates for implants:
Who Are The Key Opinion Leaders On Cochlear Implant Clinical Trial Research?
Dr. Nabil Simaan of Vanderbilt University is a Professor of Mechanical Engineering, Computer Science, and Otolaryngology.
Researchers Anthony Hogan, Merril Stewart, and Ellen Giles have made significant contributions to our understanding of how persons with cochlear implants fare in the workplace.